Amdocs Q2 FY2026 Detailed Report Reveals GAAP Profit Decline Despite Revenue Growth and Strong Buybacks
Summary
Amdocs' detailed Q2 FY2026 report shows revenue growth but a significant GAAP net income and EPS decline, influenced by restructuring and higher taxes, while the company continues substantial share buybacks and strengthens liquidity.
Key Events
-
Q2 FY2026 GAAP Profit Decline
Net income attributable to Amdocs Limited decreased 15.6% to $137.8 million, and diluted EPS fell 11.7% to $1.28 for the three months ended March 31, 2026, compared to the prior year period.
-
Revenue Growth Continues
Q2 revenue increased 3.9% to $1.17 billion, and six-month revenue grew 4.0% to $2.33 billion, driven by increased activity across all regions and contributions from recent acquisitions.
-
Substantial Share Repurchase Program
The company repurchased $284.5 million in ordinary shares during the six months ended March 31, 2026, at an average price of $75.78 per share, with $701.9 million remaining under the current authorization.
-
Enhanced Liquidity and Acquisitions
Amdocs generated $321.8 million in operating cash flow and $268.3 million in free cash flow for the six months. It also increased its revolving credit facility to $800 million and established an $800 million commercial paper program, while completing $217 million in acquisitions.
Analysis
This detailed quarterly report provides the full financial picture for Q2 FY2026, showing a notable decline in GAAP net income and diluted EPS, which contrasts with earlier reports of strong adjusted earnings. The profit reduction was primarily driven by increased restructuring charges and a higher effective tax rate. Despite this, the company demonstrated strong operational cash flow and continued its substantial share repurchase program, alongside strategic acquisitions and enhanced credit facilities, indicating active capital management and a focus on long-term growth and shareholder returns. The stock is currently trading near its 52-week low, making the GAAP profit decline a significant point of concern for investors.
At the time of this filing, DOX was trading at $62.12 on NASDAQ in the Technology sector, with a market capitalization of approximately $6.7B. The 52-week trading range was $59.40 to $95.41. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.